Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma

Emil Lou, Katherine B. Peters, Ashley L. Sumrall, Annick Desjardins, David A. Reardon, Eric S. Lipp, James E. Herndon, April Coan, Leighann Bailey, Scott Turner, Henry S. Friedman, James J. Vredenburgh

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)185-195
JournalCancer medicine
Issue number2
StatePublished - Apr 1 2013

Cite this